Get regular updates to your inbox.
The U.S. Food and Drug Administration (FDA) has expanded the label for Botox (onabotulinumtoxinA) in adults for the treatment of upper limb spasticity — a common symptom of multiple sclerosis (MS) — to include eight more muscles. The new approval will allow Botox to be used to treat…
Read more
I’ve written about trigeminal neuralgia (TN), which entails severe facial pain, many times. Let me count the ways. Please excuse me while I go off and search through my columns. I’ll be a while. Well, it turns out I’ve written specifically about it only three times,…
Is orelabrutinib one of the next big MS therapies? Biogen is betting at least $125 million that it is. Orelabrutinib is an experimental oral BTK inhibitor (BTKi). BTKi’s are designed to selectively block an enzyme that’s important for the activation of B-cells and microglia. Some of those immune cells…
“Burgers to Beat MS,” A&W Canada‘s annual fundraiser to support the MS Society of Canada and people with multiple sclerosis (MS), returns for its 13th year on Thursday, Aug. 19, aiming to raise over $1.5 million. Canada has one of the highest MS rates globally, with more than 90,000…
The Administration for Community Living (ACL) reaffirmed its support for the work of the National Paralysis Resource Center (PRC) in aiding people with paralysis — either due to multiple sclerosis (MS), accidents, or other disorders — with a five-year grant. Under a collaborative agreement, the PRC — operated…
“Change is the only constant in life,” a quote paraphrased from Greek philosopher Heraclitus states. This ancient wisdom still prevails today. Life is in a constant flux. We evolve, we grow, and we shift, and we are never the same. When I suffer, I cling to this knowledge. And…
People who develop multiple sclerosis (MS) in childhood have more difficulty recognizing words and faces than healthy individuals, a small study found. The volume of certain structures of the limbic system — a part of the brain involved in memory and emotion — is smaller in those with MS,…
Chong Kun Dang (CKD) Pharmaceutical’s experimental oral therapy CKD-506 suppressed inflammation, myelin loss (demyelination), and lessened symptoms in a mouse model of multiple sclerosis (MS), a study reported. Notably, the therapy resulted in benefits generally comparable to those of Gilenya (fingolimod) in these mice. But it also…
A signaling protein called fractalkine helps to regulate the development of oligodendrocytes, cells of the nervous system responsible for making myelin — the protecting coating of nerve cell fibers that is damaged and lost in multiple sclerosis (MS). This finding was in the study, “Fractalkine signaling regulates…
Columnist Jamie Hughes never imagined she’d get a tattoo, but she found the perfect symbol to represent her evolving journey with MS.
Columnist Ed Tobias shares top MS news, including a study finding that skin reactions are common among RRMS patients treated with Mavenclad.
Visit the Multiple Sclerosis News Today forums to connect with others in the MS community.
Becoming educated and informed about MS is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your MS journey.
There is no cure for MS yet, but there are treatments that can help manage the disease. Learn more about current therapeutic approaches here.
Get regular updates to your inbox.
